A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis
Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the effect of romosozumab on bone formation and
breakdown (resorption) and determine if romosozumab is a safe treatment for osteoporosis and
myeloma-related bone disease (MBD) in postmenopausal people with multiple myeloma (MM).